SCHEMBL25557486

SCHEMBL25557486

COc1cc(C)cc(C#Cc2nc(C(=O)OCc3ccccc3)n3ncnc(N)c23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ MAOB P27338 2/20 0.37
▸ ADORA2A P29274 2/20 0.37
▸ MAOA P21397 1/20 0.37
▸ ADORA2B P29275 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ NTRK1 P04629 2/20 0.36
▸ NTRK2 Q16620 2/20 0.36
▸ DHODH Q02127 1/20 0.36
▸ TNK2 Q07912 1/20 0.36
▸ FGFR1 P11362 8/20 0.35
▸ FGFR3 P22607 5/20 0.35
▸ FGFR2 P21802 2/20 0.35
▸ FGFR4 P22455 5/20 0.34
▸ TDP1 Q9NUW8 2/20 0.34
▸ NPY1R P25929 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ NPY2R P49146 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22696341 0.95 KDM4E (0.39) KDM4EALDH1A1MAPTMAOBADORA2A
SCHEMBL25557491 0.85 FGFR1 (0.47) KDM4EALDH1A1MAPTMAOBADORA2A
SCHEMBL25557483 0.84 MAPT (0.38) KDM4EALDH1A1MAPTMAOBADORA2A
SCHEMBL22696560 0.81 TNK2 (0.37) KDM4EALDH1A1MAPTMAOBADORA2A
SCHEMBL22696561 0.81 TNK2 (0.37) KDM4EALDH1A1MAPTMAOBADORA2A
SCHEMBL25557510 0.80 RIPK1 (0.35) NTRK1NTRK2TNK2FGFR1FGFR3
SCHEMBL25557496 0.80 RIPK1 (0.37) NTRK1NTRK2TNK2FGFR1FGFR3
SCHEMBL22696342 0.80 FGFR1 (0.51) KDM4EALDH1A1MAPTMAOBADORA2A
SCHEMBL22696339 0.79 MAPT (0.40) KDM4EALDH1A1MAPTMAOBADORA2A
SCHEMBL21050871 0.67 FGFR1 (0.69) TNK2FGFR1FGFR3FGFR2FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174535-A1 INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES KINNATE BIOPHARMA INC. 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174535-A1 INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES FGFR1, FGFR2, FGFR3 KDM4E 2504/4885ALDH1A1 2502/4885MAPT 3123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback